$SGXP SGX PHARMACEUTICALS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SGX PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SGX PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in SGX PHARMACEUTICALS, INC. for free.
IRS Number: 061523147
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SGXP
Company Address: 10505 ROSELLE STREET SAN DIEGO 92121
Former name: STRUCTURAL GENOMIX INC, date of change: 2000-10-02
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
SGX PHARMACEUTICALS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BAVP, L.P. | 10% Owner | Sell | D | 3.00 | 2,546,747 | 7,640,241 | 0 | 2.5 M to 0 (-100.00 %) |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Option Exercise | D | 7.25 | 12,500 | 90,625 | 0 | |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Option Exercise | D | 5.03 | 10,000 | 50,300 | 0 | |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Option Exercise | D | 1.35 | 10,000 | 13,500 | 0 | |
| Aug 22 2008 | SGXP | SGX PHARMACEUTICAL ... | BOCK LOUIS C | Director | Sell | D | 3.00 | 2,546,747 | 7,640,241 | 0 | 2.5 M to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | TURNER JOSEPH L | Director | Option Exercise | D | 5.00 | 12,500 | 62,500 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | TURNER JOSEPH L | Director | Option Exercise | D | 1.35 | 10,000 | 13,500 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | EASTHAM KARIN | Director | Option Exercise | D | 5.03 | 20,000 | 100,600 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | EASTHAM KARIN | Director | Option Exercise | D | 1.35 | 10,000 | 13,500 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | EASTHAM KARIN | Director | Sell | D | 3.00 | 12,500 | 37,500 | 0 | 12.5 K to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 5.21 | 30,000 | 156,300 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 5.03 | 25,000 | 125,750 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 1.35 | 20,000 | 27,000 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | HENNEY CHRISTOPHER S | Director | Sell | D | 3.00 | 97,165 | 291,495 | 0 | 97.2 K to 0 (-100.00 %) |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | RUGG TERENCE ANTHONY | CMO & VP, Drug Deve ... | Option Exercise | D | 4.75 | 3,948 | 18,753 | 0 |